Novartis CEO Says It May Consider European Private-Market Drug Launches
Novartis’ CEO said the company will consider launching drugs in private markets in Europe if the impact of most-favored-nation policies on its U.S. business is too high.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.